We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Colorectal Cancer Vaccine Proves Safe in Phase I Trial

News   Apr 26, 2019 | Original story from Sidney Kimmel Cancer Center – Jefferson Health

 
Colorectal Cancer Vaccine Proves Safe in Phase I Trial

Human colon cancer cells with the cell nuclei stained red and the protein E-cadherin stained green. Credit: Urbain Weyemi, Christophe E. Redon, William M. Bonner. NCI Center for Cancer Research

 
 
 

RELATED ARTICLES

New Opioid Accelerates Recovery Time From Pain Compared to Morphine, Preclinical Study Shows

News

A new type of opioid doesn’t have the side effects (such as increased pain sensitivity or and increased risk of chronic pain) associated with morphine and other opioid-based painkillers, and accelerates recovery time from pain compared to morphine, according to a new preclinical study.

READ MORE

Molecular Escorts Keep Cancer in Check

News

A new study by Technical University of Munich (TUM) researchers uncovers the role of special proteins, known as chaperones, in the regulation of cellular machinery in cancer cells.

READ MORE

New Open-source Solution for the Analysis of High Content Screening Data

News

A new open-source solution for the analysis of high content screening (HCS) data in biomedical research, has been released.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE